Purpose Platelet-rich plasma (PRP) therapy has been used as an adjunct to fertility
treatments in women with very low ovarian reserve and premature ovarian insufficiency …

Intraovarian platelet-rich plasma (PRP) infusion was recently introduced in the context of
addressing ovarian insufficiency. Reporting on its effectiveness prior to adopting in clinical …

Injection of intraovarian platelet-rich plasma (PRP) was recently presented in terms of
improvement ovarian function in women with a poor ovarian response (POR) or primary …

Introduction The incidence of infertility caused by diminished ovarian reserve has become a
significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has …

Objective: This study was designed to investigate if whole dimension subcortical ovarian
administration of platelet-rich plasma with gonadotropin, in proximity to most ovarian …

Objective Ovarian torsion is a common cause of local ischemic damage, reduced follicular
activity and infertility. This study aimed to investigate how well platelet‐rich plasma (PRP) …

Objective To assess the impacts of Platelet-Rich Plasma (PRP) and Granulocyte Colony-
Stimulating Factor (G-CSF) on a rat model with induced ovarian follicular damage caused by …

Abstract Background The antineoplastic agent Cyclophosphamide (CP) induces
reproductive toxicity. New strategies for protecting ovarian tissue damage in women with …

En las últimas décadas, la terapia de plasma rico en plaquetas (PRP) ha despertado mucha
atención en el área de la medicina regenerativa, siendo aplicada a diferentes patologías …

Millions of women worldwide are infertile due to gynecological disorders, including
premature ovarian insufficiency, polycystic ovary syndrome, Asherman syndrome …